Weekly Roundup: Catalent acquires Bristol-Myers Squibb’s production site, KD Pharma refinances US$166m debt facilities

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

24 Feb 2020 --- Lonza is highlighting how over half of US supplement users now seek products with sustainable origins. The company is set to showcase its range of naturally derived... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Feb 2020 --- This week in nutrition news, the US Food and Drug Administration (FDA) flagged supplementation with cesium salt as detrimental to heart health and a cause of death.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Feb 2020 --- As the number of confirmed coronavirus cases – now called COVID-19 – reaches 47,000 around the world, misinformation surrounding supplements and herbs... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 Feb 2020 --- As the coronavirus continues its spread – both within China and around the world – it is taking a serious toll on the nutrition and personal care... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

06 Feb 2020 --- Gut health is fast becoming the cornerstone of human health with research highlighting its influence on a range of health areas. From brain to skin health and... Read More

trans